로딩 중…
지수 로딩 중…
중앙백신
072020· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩9,490-2.47%
2026-06-19
Price Chart
중앙백신-4.24%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 89.76B KRW |
| Revenue | 48.42B KRW |
| Net Income | 2.89B KRW |
| Total Assets | 124.42B KRW |
| Net Assets | 106.81B KRW |
| Employees | 187 |
| Value | |
| P/E | 31.09x |
| P/B | 0.84x |
| PEG | 0.54x |
| P/S | 1.85x |
| EV/EBITDA | 45.08x |
| FCF Yield | 2.18% |
| Profitability | |
| ROE | 2.70% |
| ROA | 2.32% |
| Op. Margin | 3.83% |
| Revenue Growth | -4.90% |
| Earnings Growth | 57.65% |
| Financial Health | |
| Debt Ratio | 116.48% |
| Total Debt | 6.17B KRW |
| FCF | 1.95B KRW |
| Cash | 12.35B KRW |
| Current Ratio | 4.38x |
| Net Debt/EBITDA | -3.33x |
| Dividend | |
| Div. Yield | 2.06% |
| Div. Growth | 17.65% |
| Performance | |
| 1Y Return | -4.24% |
| 1M Return | -3.56% |
| From 52W High | -8.31% |
| 1Y MDD | -13.92% |
| Trading | |
| Volume | 13,827 shares |
| Foreign Own. | 3.13% |
| Per Share | |
| EPS | 768 KRW |
| BPS | 11,539 KRW |
Company Info
Joongang Vaccine was established in 1968 as a private enterprise, converted to a corporation in 1994, and listed on KOSDAQ in 2003. Headquartered in Yuseong-gu, Daejeon, it manufactures about 80 types of animal vaccines for disease prevention, selling them to farms, distributors, and animal hospitals, and provides feed additive sales, rabies testing, disease diagnosis, and research services for biological products. With strengthened antibiotic regulations, the focus is shifting from treatment to prevention, increasing demand for animal vaccines, and the company is developing new markets in Southeast Asia, South America, and China.